Latest Lundbeck Stories
EVANSTON, Ill., May 11, 2011 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.
NEW YORK, Feb. 24, 2011 /PRNewswire/ -- Get content from Lundbeck at: http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=aa3126b8-011d-4687-90e0-fad014366811 Full year revenue was DKK 14,765 million and increased 7% compared to 2009, driven by a positive development in all regions.
PARSIPPANY, N.J., Jan.
Ian Read, President and Chief Executive Officer, Pfizer Jerzy Gruhn, President, Novo Nordisk Inc. Mark Iwicki, President and Chief Operating Officer, Sunovion Pharmaceuticals Inc. Staffan Schuberg, President, Lundbeck Inc. WASHINGTON, Dec.
LA JOLLA, Calif., Dec. 16, 2010 /PRNewswire/ -- Zenobia Therapeutics, Inc. (Zenobia) the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H.